{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:51:26Z","timestamp":1791471086681,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1124\/jpet.109.160465","type":"journal-article","created":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T04:20:16Z","timestamp":1254889216000},"page":"66-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Critical Cysteine Residues of Kelch-Like ECH-Associated Protein 1 in Arsenic Sensing and Suppression of Nuclear Factor Erythroid 2-Related Factor 2"],"prefix":"10.1016","volume":"332","author":[{"given":"Xiaoqing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.109.160465_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1289\/ehp.99107593","article-title":"Arsenic: health effects, mechanisms of actions, and research issues","volume":"107","author":"Abernathy","year":"1999","journal-title":"Environ Health Perspect"},{"key":"10.1124\/jpet.109.160465_bib2","series-title":"Protein Protocol Handbook","first-page":"487","article-title":"Estimation of disulfide bonds using Ellman's regent","author":"Aitken","year":"1996"},{"key":"10.1124\/jpet.109.160465_bib3","series-title":"Toxicological profile for arsenic (update)","year":"2005"},{"key":"10.1124\/jpet.109.160465_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/361173a0","article-title":"Arsenical-resistant trypanosomes lack an unusual adenosine transporter","volume":"361","author":"Carter","year":"1993","journal-title":"Nature"},{"key":"10.1124\/jpet.109.160465_bib5","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1073\/pnas.081082098","article-title":"An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen","volume":"98","author":"Chan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.109.160465_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1165\/ajrcmb.26.2.4501","article-title":"Role of NRF2 in protection against hyperoxic lung injury in mice","volume":"26","author":"Cho","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.109.160465_bib7","doi-asserted-by":"crossref","first-page":"11908","DOI":"10.1073\/pnas.172398899","article-title":"Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants","volume":"99","author":"Dinkova-Kostova","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.109.160465_bib8","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1073\/pnas.0500815102","article-title":"Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress","volume":"102","author":"Dinkova-Kostova","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.109.160465_bib9","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1073\/pnas.0502402102","article-title":"Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2","volume":"102","author":"Eggler","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.109.160465_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0190-9622(92)70232-5","article-title":"History of the treatment of psoriasis","volume":"27","author":"Farber","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1124\/jpet.109.160465_bib11","unstructured":"Gomez-Caminero A, Howe P, Hughes MF, Kenyon E, Lewis DR, Moore M, Ng J, Aitio A, Becking G (2001) Environmental Health Criteria 224: arsenic and arsenic compounds, in International Program on Chemical Safety (Ng J ed), World Health Organization, Geneva."},{"key":"10.1124\/jpet.109.160465_bib12","doi-asserted-by":"crossref","first-page":"23620","DOI":"10.1074\/jbc.M604120200","article-title":"Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 \u00b7 Keap1 \u00b7 Cul3 complex and recruiting Nrf2 \u00b7 Maf to the antioxidant response element enhancer","volume":"281","author":"He","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.160465_bib13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1021\/tx800019a","article-title":"Activation of Nrf2 in defense against cadmium-induced oxidative stress","volume":"21","author":"He","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/jpet.109.160465_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yjmcc.2008.10.007","article-title":"Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes","volume":"46","author":"He","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.109.160465_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/toxsci\/kfm081","article-title":"Protection against chromium (VI)-induced oxidative stress and apoptosis by Nrf2. Recruiting Nrf2 into the nucleus and disrupting the nuclear Nrf2\/Keap1 association","volume":"98","author":"He","year":"2007","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.109.160465_bib16","doi-asserted-by":"crossref","DOI":"10.1124\/mol.109.058453","article-title":"Nrf2 cysteine residues are critical for oxidant\/electrophile-sensing, Keap1-dependent ubiquitination-proteasomal degradation, and transcription activation","author":"He","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.109.160465_bib17","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1021\/tx0502138","article-title":"Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane","volume":"18","author":"Hong","year":"2005","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/jpet.109.160465_bib18","doi-asserted-by":"crossref","first-page":"31768","DOI":"10.1074\/jbc.M503346200","article-title":"Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation","volume":"280","author":"Hong","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.160465_bib19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/MCB.26.3.940-954.2006","article-title":"Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice","volume":"26","author":"Hu","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.109.160465_bib20","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.2353\/ajpath.2007.060898","article-title":"Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2","volume":"170","author":"Hubbs","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.109.160465_bib21","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.109.160465_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1128\/MCB.01080-08","article-title":"The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds","volume":"29","author":"Kobayashi","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.109.160465_bib23","doi-asserted-by":"crossref","first-page":"48021","DOI":"10.1074\/jbc.M308439200","article-title":"Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress","volume":"278","author":"Leung","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.160465_bib24","series-title":"Casarett & Doull's Toxicology The Basic Science of Poisons","first-page":"931","article-title":"Toxic effects of metals","author":"Liu","year":"2008"},{"key":"10.1124\/jpet.109.160465_bib25","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/tx800156s","article-title":"Xenobiotic-activated receptors: from transcription to drug metabolism to disease","volume":"21","author":"Ma","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/jpet.109.160465_bib26","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2353\/ajpath.2006.051113","article-title":"Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2","volume":"168","author":"Ma","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.109.160465_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/bj20031123","volume":"377","author":"Ma","year":"2004","journal-title":"Biochem J"},{"key":"10.1124\/jpet.109.160465_bib28","doi-asserted-by":"crossref","first-page":"12676","DOI":"10.1074\/jbc.275.17.12676","article-title":"Superinduction of CYP1A1 gene expression. Regulation of 2,3,7, 8-tetrachlorodibenzo-p-dioxin-induced degradation of Ah receptor by cycloheximide","volume":"275","author":"Ma","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.109.160465_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj3560621","article-title":"Tributyltin interacts with mitochondria and induces cytochrome c release","volume":"356","author":"Nishikimi","year":"2001","journal-title":"Biochem J"},{"key":"10.1124\/jpet.109.160465_bib30","unstructured":"NRC (2001) Arsenic in the Drinking Water (update). National Research Council, National Academy Press, Washington DC."},{"key":"10.1124\/jpet.109.160465_bib31","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.051618798","article-title":"Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice","volume":"98","author":"Ramos-Gomez","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.109.160465_bib32","series-title":"Environmental and Occupational Medicine","first-page":"1006","article-title":"Arsenic","author":"Rossman","year":"2007"},{"key":"10.1124\/jpet.109.160465_bib33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1073\/pnas.0804333106","article-title":"Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice","volume":"106","author":"Sussan","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.109.160465_bib34","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute promyelocytic leukemia: from highly fatal to highly curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"10.1124\/jpet.109.160465_bib35","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1128\/MCB.01704-07","article-title":"Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity","volume":"28","author":"Yamamoto","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.109.160465_bib36","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1128\/MCB.23.22.8137-8151.2003","article-title":"Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress","volume":"23","author":"Zhang","year":"2003","journal-title":"Mol Cell Biol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524456218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524456218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.109.160465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:04:15Z","timestamp":1740017055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524456218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0022356524456218"],"URL":"https:\/\/doi.org\/10.1124\/jpet.109.160465","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical Cysteine Residues of Kelch-Like ECH-Associated Protein 1 in Arsenic Sensing and Suppression of Nuclear Factor Erythroid 2-Related Factor 2","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.109.160465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}